Custom CD Marker Antibodies: Core Immunophenotyping Tools for Mapping Comprehensive Immune Cell Landscapes
Core Biological Definition & Research Value of Cluster of Differentiation Molecules
Cluster of Differentiation (CD) markers represent standardized leukocyte surface glycoprotein nomenclature systems established by international immunology working groups, covering over 370 distinct transmembrane antigens distributed across all hematopoietic cell lineages. Each CD molecule serves dual experimental functions as lineage identification signatures and functional signal mediators regulating cell adhesion, chemotaxis, activation and cytokine secretion cascades. Multi-parameter flow cytometry and spatial tissue profiling pipelines rely on matched CD antibody panels to resolve heterogeneous immune subpopulations within peripheral blood, spleen and tumor microenvironment specimens. Standard commercial antibody catalogs cannot fully satisfy advanced immunology screening demands, as emerging immune checkpoint CD targets, species-specific epitopes and polarization-specific surface antigens lack validated off-the-shelf detection clones. Custom CD antibody development services from ANT BIO PTE. LTD. deliver epitope-tailored reagents for high-resolution immune cell atlas construction and immunological mechanism dissection.
CD Antibody Applications for T Lymphocyte Subset Immunophenotyping
CD antibody combinations form the gold standard for stratifying functionally distinct T cell populations in murine and human preclinical samples. Core lineage markers CD3, CD4 and CD8 separate helper and cytotoxic T cell compartments, while paired CD45RA/CCR7 antibodies distinguish naive, central memory and effector memory T subsets. Transcription factor co-staining with RORγt paired with CD4 enables Th17 cell quantification in autoimmune disease model tissues. Tumor-infiltrating exhausted T cells require multiplex panels combining CD8 with inhibitory checkpoint CD markers PD-1, TIM-3 and LAG-3 to track immune suppression gradients across lesion microdomains. Custom fluorophore-conjugated CD antibodies support 20+ color spectral flow cytometry workflows for single-cell transcriptomic sorting and longitudinal immune cohort monitoring assays.
CD Marker Panels for B Cell and NK Cell Population Classification
Systematic B cell developmental staging depends on tiered CD antigen expression profiles detectable via matched antibody sets. CD19 acts as pan-B lineage identifier, while CD20 marks immature to mature B cells, CD27 labels memory B subsets and CD38/CD138 co-expression identifies antibody-secreting plasma cell populations. Custom CD antibody cocktails resolve pro-B, transitional and germinal center B cell fractions within lymphoid organ single-cell suspensions. Natural killer cell profiling utilizes CD16 and CD56 antibodies to separate cytotoxic CD56dim and immunoregulatory CD56bright NK subpopulations. Combined CD94/NKG2 marker staining quantifies NK cell inhibitory receptor remodeling following viral infection or tumor co-culture stimulation cycles in vitro experimental systems.
Myeloid Cell CD Antibody Reagents for Monocyte, DC and Granulocyte Profiling
Diverse myeloid subpopulations require specialized CD antibody combinations to resolve polarization and developmental states. Classical monocytes display high CD14 expression, while non-classical subsets carry elevated CD16 surface density; paired CD68/CD163 antibodies distinguish M1 and M2 polarized tumor-associated macrophage subgroups. Dendritic cell typing relies on CD11c for myeloid DCs and CD123/CD303 for plasmacytoid DC populations to map antigen-presenting cell distribution in inflamed tissue sections. Granulocyte identification utilizes CD15 and CD66b for neutrophils, CD125 for eosinophils and CD203c for basophil subsets during infection and allergic reaction model screening campaigns.
CD Checkpoint & Co-Stimulatory Antibodies for Tumor Immunity Research
Immune regulatory CD molecules form core intervention targets for preclinical immunotherapy mechanism research. Inhibitory checkpoint CD markers PD-1, CTLA-4, TIGIT and LAG-3 quantify T cell exhaustion levels within solid tumor microenvironments. Co-stimulatory surface antigens CD28, ICOS, OX40 and 4-1BB amplify anti-tumor lymphocyte effector function upon ligand engagement. Custom blocking and detection CD antibodies serve dual research roles: flow cytometry quantifies checkpoint expression gradients, while neutralization clones enable in vitro co-culture functional validation of immune reactivation signaling pathways. Stratified CD biomarker profiling guides combinatorial checkpoint antibody screening and therapeutic response prediction in xenograft tumor cohorts.
CD Antibodies for Hematological Malignancy Subtyping Assays
Multi-CD immunophenotyping panels constitute primary stratification tools for blood tumor basic research model characterization. B-cell lymphoma screening combines CD19, CD20, CD10 and CD79b antibody markers to separate distinct malignant B clones. T cell neoplasm identification utilizes CD3, CD4, CD8 and CD30 CD reagent combinations. Acute myeloid leukemia profiling relies on CD13, CD33, CD34 and CD117 surface marker panels to classify precursor malignant populations. Plasma cell myeloma detection leverages CD38, CD138 and BCMA CD antibodies to quantify aberrant plasma cell infiltration in bone marrow tissue homogenates. Custom matched CD antibody pairs support minimal residual cell detection for long-term tumor progression monitoring experiments.
End-to-End Custom CD Antibody Development Platform from ANT BIO PTE. LTD.
ANT BIO PTE. LTD. operates integrated single B cell recombinant rabbit monoclonal pipelines dedicated to CD marker antibody custom development. The full service workflow includes bioinformatic epitope screening, synthetic peptide or mammalian recombinant antigen production, multi-round animal immunization and high-throughput B cell clonal isolation. Multi-step chromat purification delivers antibody purity above 95% with controllable endotoxin concentrations below 1.0 EU/μg for in vivo murine administration assays. All custom CD clones complete cross-platform validation covering flow cytometry, IHC, WB, IP and immunofluorescence imaging. Flexible customization options include variable antibody formats (IgG, Fab, scFv), species cross-reactivity tuning and site-specific fluorophore/biotin covalent labeling for multi-color immune profiling workflows.
Fundamental Research Applications of ANT BIO PTE. LTD. Custom CD Antibodies
FFPE spleen and tumor tissue microarray IHC maps spatial immune cell infiltration gradients via multiplex CD marker co-staining workflows. High-dimensional spectral flow cytometry utilizes custom fluorophore CD antibody panels to sort distinct immune subpopulations for downstream scRNA-seq transcriptomic analysis. Western blot analysis quantifies dynamic CD antigen expression shifts following cytokine or checkpoint antibody co-culture stimulation cycles. Immunoprecipitation assays isolate CD surface receptor multi-protein complexes to dissect immune cell adhesion and intracellular signal transduction cascades. In vivo immune depletion experiments rely on low-endotoxin CD neutralizing antibodies to validate cell subset functional contributions in infection and tumor preclinical model systems.
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANT BIO PTE. LTD., we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.
